Satellos Bioscience Inc. Opens the Market
15 Maio 2024 - 12:04PM
PR Newswire (US)
TORONTO, May 15, 2024
/PRNewswire/ - Frank Gleeson Co-Founder and Chief Executive
Officer, Satellos Bioscience Inc. (TSX: MSCL) ("Satellos" or the
"Company"), and his team joined Dani
Lipkin, Managing Director, Global Innovation Sector, Toronto
Stock Exchange (TSX), to open the market and celebrate the
Company's graduation to TSX.
Satellos is a publicly traded biotechnology company dedicated to
developing life-improving medicines to treat degenerative muscle
diseases. For more information, visit www.satellos.com.
CNW sponsored announcement. To learn more
visit www.newswire.ca.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/satellos-bioscience-inc-opens-the-market-302146505.html
SOURCE Toronto Stock Exchange
Copyright 2024 PR Newswire
Satellos Bioscience (TSX:MSCL)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Satellos Bioscience (TSX:MSCL)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024